The “Next Frontier” for Pioneering Cancer Therapies

February 4, 2022

(Axios) – Cancer treatments that modify a patient’s immune cells to attack cancer cells are being re-engineered to try to treat more cancers in more people. Why it matters: CAR-T immunotherapies have been successful in treating certain types of blood cancers in some people. But they struggle against solid tumors, which make up about 90% of cancers in adults. (Read More)